Satoru Tamaoki

460 total citations
17 papers, 374 citations indexed

About

Satoru Tamaoki is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Satoru Tamaoki has authored 17 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in Satoru Tamaoki's work include Nitric Oxide and Endothelin Effects (6 papers), Gastrointestinal motility and disorders (3 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Satoru Tamaoki is often cited by papers focused on Nitric Oxide and Endothelin Effects (6 papers), Gastrointestinal motility and disorders (3 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Satoru Tamaoki collaborates with scholars based in Japan and New Zealand. Satoru Tamaoki's co-authors include Hiroshi Azuma, Hiroshi Masuda, Moritaka Goto, Tsugitaka Natsume, Motohiro Kobayashi, Junichi Watanabe, Katsuhiko Miyasaka, Michitaka Sato, Hidehisa Hamasaki and Jun Sato and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Satoru Tamaoki

17 papers receiving 357 citations

Peers

Satoru Tamaoki

PHYSI

MB

CCM

OC

ONCOL

Brenda R. Flam United States

Laura González-Santiago Spain

Masaki Hashimoto Japan

F. S. TJOENG United States

Yasuhiro Egi Japan

Markus Follmann Germany

Haruhisa Yamashita Japan

Yukio Motoyama Japan

Hyehun Choi United States

Jeffrey Tong Canada

Brenda R. Flam United States

Satoru Tamaoki

224 ×1.7

PHYSI

251 ×1.9

MB

61 ×0.8

CCM

47 ×0.7

OC

20 ×0.4

ONCOL

Citations per year, relative to Satoru Tamaoki Satoru Tamaoki (= 1×) peers Brenda R. Flam

Countries citing papers authored by Satoru Tamaoki

Since Specialization

Citations

This map shows the geographic impact of Satoru Tamaoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoru Tamaoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoru Tamaoki more than expected).

Fields of papers citing papers by Satoru Tamaoki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoru Tamaoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoru Tamaoki. The network helps show where Satoru Tamaoki may publish in the future.

Co-authorship network of co-authors of Satoru Tamaoki

This figure shows the co-authorship network connecting the top 25 collaborators of Satoru Tamaoki. A scholar is included among the top collaborators of Satoru Tamaoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoru Tamaoki. Satoru Tamaoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

1.

Ikeuchi, Kazuhiko, Takeya Tsutsumi, Aya Ishizaka, et al.. (2023). Modulation of duodenal and jejunal microbiota by rifaximin in mice with CCl4-induced liver fibrosis. Gut Pathogens. 15(1). 14–14. 1 indexed citations

2.

Tamaoki, Satoru, et al.. (2016). Development of an experimental rat model of hyperammonemic encephalopathy and evaluation of the effects of rifaximin. European Journal of Pharmacology. 779. 168–176. 10 indexed citations

3.

Matsui, Teruaki, et al.. (2010). Discovery of a Novel 5-HT₃ Antagonist/5-HT_1A Agonist 3-Amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an Orally Bioavailable Agent for Irritable Bowel Syndrome. Journal of Medicinal Chemistry. 53(21). 7549–7563. 22 indexed citations

4.

Matsui, Teruaki, et al.. (2009). Design and Synthesis of Piperazinylpyridine Derivatives as Novel 5-HT1A Agonists/5-HT3 Antagonists for the Treatment of Irritable Bowel Syndrome (IBS). Chemical and Pharmaceutical Bulletin. 57(1). 34–42. 19 indexed citations

5.

Tamaoki, Satoru, et al.. (2007). Pharmacological Properties of 3-Amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3 H)-one (TZB-30878), a Novel Therapeutic Agent for Diarrhea-Predominant Irritable Bowel Syndrome (IBS) and Its Effects on an Experimental IBS Model. Journal of Pharmacology and Experimental Therapeutics. 322(3). 1315–1323. 21 indexed citations

6.

Natsume, Tsugitaka, et al.. (2000). Characterization of the Interaction of TZT‐1027, a Potent Antitumor Agent, with Tubulin. Japanese Journal of Cancer Research. 91(7). 737–747. 45 indexed citations

7.

Masuda, Hiroshi, Moritaka Goto, Satoru Tamaoki, & Hiroshi Azuma. (1999). Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan‐induced hyperglycaemia. British Journal of Pharmacology. 126(1). 211–218. 88 indexed citations

8.

Azuma, Hiroshi, Jun Sato, Hiroshi Masuda, et al.. (1999). ATZ1993, an Orally Active and Novel Nonpeptide Antagonist for Endothelin Receptors and Inhibition of Intimal Hyperplasia After Balloon Denudation of the Rabbit Carotid Artery. The Japanese Journal of Pharmacology. 81(1). 21–28. 3 indexed citations

9.

Azuma, Hiroshi, Jun Sato, Hiroshi Masuda, et al.. (1999). ATZ1993, an Orally Active and Novel Nonpeptide Antagonist for Endothelin Receptors and Inhibition of Intimal Hyperplasia After Balloon Denudation of the Rabbit Carotid Artery. The Japanese Journal of Pharmacology. 81(1). 21–28. 10 indexed citations

10.

Sato, Jun, Satoru Tamaoki, Hidehisa Hamasaki, et al.. (1998). Endogenous asymmetrical dimethylarginine and hypertension associated with puromycin nephrosis in the rat. British Journal of Pharmacology. 125(3). 469–476. 13 indexed citations

11.

Masuda, Hiroshi, et al.. (1998). M3-Type Muscarinic Receptors Predominantly Mediate Neurogenic Quick Contraction of Bovine Ciliary Muscle. General Pharmacology The Vascular System. 30(4). 579–584. 9 indexed citations

12.

Kobayashi, Motohiro, Tsugitaka Natsume, Satoru Tamaoki, et al.. (1997). Antitumor Activity of TZT‐1027, a Novel Doiastatin 10 Derivative. Japanese Journal of Cancer Research. 88(3). 316–327. 78 indexed citations

13.

Masuda, Hiroshi, Satoru Tamaoki, Moritaka Goto, et al.. (1997). Nitric oxide-induced ciliary muscle relaxation during contraction with endothelin-1 is mediated through elevation of cyclic GMP. Current Eye Research. 16(12). 1245–1251. 11 indexed citations

14.

Hamasaki, Hidehisa, Jun Sato, Hiroshi Masuda, et al.. (1997). Effect of nicotine on the intimal hyperplasia after endothelial removal of the rabbit carotid artery. General Pharmacology The Vascular System. 28(5). 653–659. 39 indexed citations

15.

Kurihara, Junichi, Satoru Tamaoki, & Hitoshi Kato. (1993). Blockade of α2-adrenoceptors protects the vagal baroreflex system from transient global cerebral ischemia in dogs. European Journal of Pharmacology. 240(1). 73–76. 2 indexed citations

16.

Tamaoki, Satoru, et al.. (1992). MK-801 Prevents the Post-Ischemic Cerebral Hypoperfusion, but Not the Dysfunction of the Vagal Baroreflex in Dogs. The Japanese Journal of Pharmacology. 59(2). 243–245. 2 indexed citations

17.

Tamaoki, Satoru, Junichi Kurihara, & Hitoshi Kato. (1992). Mechanism of the protective effect of ifenprodil against the dysfunction of baroreflex following cerebral ischemia. The Japanese Journal of Pharmacology. 58. 109–109. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact